Search

everythinglearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Start low-dose minoxidil gradually, especially for women, to reduce side effects.

Finasteride 1 mg every other month effectively maintains hair growth in androgenic alopecia.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Oral minoxidil effectively controls blood pressure quickly and safely.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Exosomes show promise in skin and hair treatments, but more research is needed to ensure their safety and effectiveness.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The FDA approved a new Pfizer drug for hair loss in teens.

Low dose valproic acid treatment caused hair loss in a young patient.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

An infant with a zinc deficiency skin disorder improved with zinc treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Ringworm of the body and scalp is treated with antifungal creams and oral medication, and children with scalp ringworm don't need to miss school.

Dosing time affects finasteride's effectiveness and safety in rats.

Taking the same medication under different brand names caused harmful side effects.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

All four treatments for early rheumatoid arthritis had similar safety profiles.